Utidelone in Combination With AC Versus Docetaxel in Combination With AC for Neoadjuvant Chemotherapy in Patients With HER2-negative Breast Cancer
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Utidelone Injection in combination with AC|DRUG: Docetaxel Injection in combination with AC
Sponsor: Beijing Biostar Pharmaceuticals Co., Ltd.